首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >A Brazilian experience in assisted automated peritoneal dialysis: A reliable and effective home care approach
【24h】

A Brazilian experience in assisted automated peritoneal dialysis: A reliable and effective home care approach

机译:巴西在辅助性自动腹膜透析方面的经验:可靠而有效的家庭护理方法

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Automated assisted peritoneal dialysis (AAPD) has been shown to be successful as renal replacement therapy for elderly and physically incapable end-stage renal disease (ESRD) patients. In early 2003, a pioneer AAPD program was initiated at GAMEN Renal Clinic in Rio de Janeiro, Brazil. Objective: We evaluated the results of an AAPD program offered as an option to elderly ESRD patients with physical or cognitive debilities or as last resort to patients with vascular access failure or hemodynamic instability during hemodialysis. Methods: A cohort of 30 consecutive patients started AAPD from January 2003 to March 2008 and was followed to July 2009. Demographics, clinical and laboratory parameters, causes of death, and patient and technique survival were analyzed. Results: Median age of the patients was 72 years (range: 47 - 93 years), with 60% being older than 65. The Davies score was greater than 2 in 73% of patients, and the Karnofsky index was less than 70 in 40%. The overall peritonitis rate was 1 episode in 37 patient-months. The total duration of AAPD ranged from 3 to 72 months. Patient survival was 80% at 12 months, 60% at 24 months, and 23.3% at 48 months. The most common cause of death was cardiovascular problems (70%). Conclusions: In this clinical observational study, AAPD fulfilled its expected role, offering an opportune, reliable, and effective homecare alternative for ESRD patients with no other renal replacement therapy options.
机译:简介:自动辅助腹膜透析(AAPD)已被证明可成功地用于老年和身体残障的终末期肾病(ESRD)患者的肾脏替代治疗。 2003年初,在巴西里约热内卢的GAMEN肾脏诊所启动了AAPD先锋计划。目的:我们评估了AAPD计划的结果,该计划可作为有生理或认知功能障碍的老年ESRD患者的选择,或作为血液透析期间血管通路衰竭或血液动力学不稳定的患者的最后选择。方法:从2003年1月至2008年3月,连续30例患者开始AAPD,随后至2009年7月。分析了人口统计学,临床和实验室参数,死亡原因以及患者和技术存活率。结果:患者的中位年龄为72岁(范围:47-93岁),其中60%的年龄大于65岁。73%的患者的Davies得分大于2,而40的Karnofsky指数小于70 %。在37个患者月中,总的腹膜炎发生率为1次。 AAPD的总持续时间为3至72个月。患者存活率在12个月时为80%,在24个月时为60%,在48个月时为23.3%。最常见的死亡原因是心血管问题(70%)。结论:在这项临床观察性研究中,AAPD发挥了其预期的作用,为没有其他肾脏替代疗法的ESRD患者提供了一种机会,可靠和有效的家庭护理选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号